NASDAQ: AKTS · Health Care / Biotechnology: Pharmaceutical Preparations

Aktis Oncology Inc.

How Aktis Oncology Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$937.2M

Price

$16.85

P/E

-11.9

EPS (TTM)

$-1.41

Dividend yield

0.0%

52-week range

$15.06–$19.47

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources